MGB Biopharma Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MGB Biopharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014168
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MGB Biopharma Ltd (MGB) is a clinical stage biopharmaceutical company which develops anti-infective medicine of minor groove binder (MGBs) compounds. The company focuses on the development of new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. It offers its lead drug candidate, MGB-BP-3 in the field of antibacterial resistance. The company provides programmes which include Oral, gram-positive IV, topical, gram negative, anti-fungal, anti-viral, anti-parasitic. It provides anti-infective platform solutions to deliver drugs against multi-resistant Gram-negative pathogens, viruses, fungi and parasitic diseases. The company seeks to work in partnership with research institutes and pharmaceutical companies in the antibiotics field.MGB is headquartered in Glasgow, the UK.

MGB Biopharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MGB Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MGB Biopharma Raises USD1.2 Million in Venture Financing 10
MGB Biopharma Raises USD4.4 Million in Venture Financing 11
MGB Biopharma Raises US$1 Million In Venture Financing 12
MGB Biopharma Raises US$1.2 Million In Venture Financing 14
Partnerships 15
MGB Biopharma Enters into Agreement with University of Strathclyde 15
MGB Biopharma Ltd – Key Competitors 16
MGB Biopharma Ltd – Key Employees 17
MGB Biopharma Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
05/19/2016: MGB Biopharma Welcomes Jim O Neill Final Recommendations for the World to Defeat Superbugs 19
Product Approvals 20
May 09, 2016: MGB Biopharma’s Pre-IND Meeting with FDA Provides Clear Guidelines on Further Development of Oral MGB-BP-3, a Truly Novel Antibiotic Targeting Clostridium difficile Infections 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MGB Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MGB Biopharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MGB Biopharma Raises USD1.2 Million in Venture Financing 10
MGB Biopharma Raises USD4.4 Million in Venture Financing 11
MGB Biopharma Raises US$1 Million In Venture Financing 12
MGB Biopharma Raises US$1.2 Million In Venture Financing 14
MGB Biopharma Enters into Agreement with University of Strathclyde 15
MGB Biopharma Ltd, Key Competitors 16
MGB Biopharma Ltd, Key Employees 17

★海外企業調査レポート[MGB Biopharma Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OSI Maritime Systems:企業の戦略・SWOT・財務情報
    OSI Maritime Systems - Strategy, SWOT and Corporate Finance Report Summary OSI Maritime Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vossloh AG:企業の戦略・SWOT・財務情報
    Vossloh AG - Strategy, SWOT and Corporate Finance Report Summary Vossloh AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務分析
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Dicerna Pharmaceuticals Inc (DRNA)-製薬・医療分野:企業M&A・提携分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies.The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. Its pipeline product is being generated from the company’s propri …
  • Bajaj Allianz General Insurance Company Limited:企業の戦略・SWOT・財務分析
    Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Petrel Energy Ltd (PRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrel Energy Ltd (Petrel Energy), formerly Orion Petroleum Ltd, is an petroleum exploration, development and production company. The company offers exploitation of petroleum products and produces crude oil using conventional and unconventional methods. It holds tenements in the Norte Basin, …
  • Vigor Shipyards, Inc:企業の戦略・SWOT・財務分析
    Vigor Shipyards, Inc - Strategy, SWOT and Corporate Finance Report Summary Vigor Shipyards, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AGL Energy Limited:企業の戦略・SWOT・財務分析
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Asian Hotels (North) Limited:企業の戦略・SWOT・財務情報
    Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report Summary Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bactiguard Holding AB (BACTI B):医療機器:M&Aディール及び事業提携情報
    Summary Bactiguard Holding AB (Bactiguard) is a medical device manufacturer which develops and supplies infection protection solutions and antibiotics. The company’s product portfolio includes urinary catheters, foley catheters (BIP Foley catheters), endotracheal tubes and central venous catheters. …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Advicenne SA (ADVIC)-製薬・医療分野:企業M&A・提携分析
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company’s product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It offer …
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • Eloro Resources Ltd (ELO):企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …
  • Contango Oil & Gas Co (MCF):石油・ガス:M&Aディール及び事業提携情報
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Riverbed Technology, Inc.:企業の戦略的SWOT分析
    Riverbed Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析
    e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆